From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: From Fear to Purpose (Acceptance and Commitment Therapy), Placebo.
- Кому может быть актуально
- Состояния в реестре: Death Anxiety, Depression, Anxiety. Базовые параметры: 18 лет — 65 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Список центров уточняется — проверьте первичный протокол.
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
From Fear to Purpose ACT Protocol: Testing Indirect, Transdiagnostic Implications of Death Anxiety Over Depression and Anxiety. A Randomized Placebo Controlled Trial.
Обзор
The main purpose of this placebo controlled trial is to test the efficacy of a one-session From Fear to Purpose ACT intervention in reducing self-reported death anxiety levels. Another objective of this study is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.
Подробное описание
This is a placebo controlled trial where the main objective is to test if the one-session From Fear to Purpose ACT intervention is effective in reducing self-reported death anxiety levels. A secondary objective is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.
Participants will be selected based on death anxiety levels (moderate-high scores) and depression and anxiety symptoms (subclinical levels). Minors, people with suicidal ideation, people with current psychological/psychiatric diagnosis (excepting depression or anxiety diagnosis), people in active psychological/psychiatric treatment will be excluded. Recruited participants will be randomized into two groups: the experimental group (will receive the From Fear to Purpose ACT intervention) and the placebo group. The placebo condition will be undergoing a group-based attentional control activity. Participants will be blinded to the study condition.
The From Fear to Purpose intervention protocol is based on Acceptance and Commitment Therapy (ACT) strategies, build around identifying and committing to personal values. The intervention will be group-based (90 minutes session). The intervention will be administered by experienced psychotherapists.
The primary outcome is death anxiety, while secondary outcomes are depression and anxiety symptoms, well-being, psychological flexibility, experiential avoidance and valued living.
Вмешательства
- Другое From Fear to Purpose (Acceptance and Commitment Therapy)
The From Fear to Purpose ACT Protocol is based on Acceptance and Commitment Therapy (ACT) strategies, build around identifying and committing to personal values. The intervention will be group-based (90 minutes session). - Другое Placebo
The placebo condition consists of a group-based attentional control intervention.
Первичные конечные точки
- Change from baseline Death Anxiety score to the follow-up moment (6 weeks duration) [Срок оценки: From enrolment to follow-up (6 weeks time frame)]
Вторичные конечные точки (6)
- Change from baseline Depression score to the follow-up moment (6 weeks duration) [Срок оценки: From enrolment to follow-up (6 weeks time frame)]
- Change from baseline Anxiety score to the follow-up moment (6 weeks duration [Срок оценки: From enrolment to follow-up (6 weeks time frame)]
- Change from baseline Well-being score to the follow-up moment (6 weeks duration) [Срок оценки: From enrolment to follow-up (6 weeks time frame)]
- Change from baseline Psychological Flexibility to the follow-up moment (6 weeks duration) [Срок оценки: From enrolment to follow-up (6 weeks time frame)]
- Change from baseline Experiential Avoidance score to the follow-up moment (6 weeks duration [Срок оценки: From enrolment to follow-up (6 weeks time frame)]
- Change from baseline Valued Living score to the follow-up moment (6 weeks duration [Срок оценки: From enrolment to follow-up (6 weeks time frame)]
Критерии участия
Критерии включения
- Moderate-high levels of death anxiety (score > or = 55) AND
- Subclinical levels of depression (score > or = 9) AND/OR
- Subclinical levels of anxiety (score > or = 9)
Критерии исключения
- Minors
- Suicidal ideation
- Current psychological/psychiatric diagnosis (except depression or anxiety diagnosis)
- Active psychological/psychiatric treatment
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Рандомизированное
- Модель
- Параллельные группы
- Маскирование
- Двойное слепое
- Основная цель
- Лечение
Центры проведения
Список центров уточняется — проверьте первичный протокол.
Идентификаторы
NCT: NCT06810999 · 816/22.01.2025